EGFR and neoplasm: Zhou et al. found that down-regulated expression of linc00152 was able to inhibit tumor growth in vivo and in vitro, and RNA immunoprecipitation (RIP) experiment showed that linc00152 could directly bind to epidermal growth factor receptor (EGFR).